153 related articles for article (PubMed ID: 37100231)
21. Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments.
Iwakura K
J Echocardiogr; 2019 Dec; 17(4):177-186. PubMed ID: 31617144
[TBL] [Abstract][Full Text] [Related]
22. Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart.
Rieth AJ; Richter MJ; Tello K; Gall H; Ghofrani HA; Guth S; Wiedenroth CB; Seeger W; Kriechbaum SD; Mitrovic V; Schulze PC; Hamm CW
Clin Res Cardiol; 2022 Apr; 111(4):393-405. PubMed ID: 34110459
[TBL] [Abstract][Full Text] [Related]
23. Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.
Rao S
Adv Ther; 2022 Feb; 39(2):845-861. PubMed ID: 34881413
[TBL] [Abstract][Full Text] [Related]
24. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.
Ghio S; Guazzi M; Scardovi AB; Klersy C; Clemenza F; Carluccio E; Temporelli PL; Rossi A; Faggiano P; Traversi E; Vriz O; Dini FL;
Eur J Heart Fail; 2017 Jul; 19(7):873-879. PubMed ID: 27860029
[TBL] [Abstract][Full Text] [Related]
25. Echocardiography of right ventricular-arterial coupling predicts survival of elderly patients with heart failure and reduced to mid-range ejection fraction.
Rosa GM; D'Agostino A; Giovinazzo S; La Malfa G; Fontanive P; Miccoli M; Dini FL
Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32425012
[TBL] [Abstract][Full Text] [Related]
26. Echocardiographic predictors of exercise intolerance in patients with heart failure with severely reduced ejection fraction.
Zaborska B; Smarż K; Makowska E; Czepiel A; Świątkowski M; Jaxa-Chamiec T; Budaj A
Medicine (Baltimore); 2018 Jul; 97(28):e11523. PubMed ID: 29995821
[TBL] [Abstract][Full Text] [Related]
27. Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis.
Zhang N; Wang Y; Tse G; Korantzopoulos P; Letsas KP; Zhang Q; Li G; Lip GYH; Liu T
Eur J Prev Cardiol; 2022 Feb; 28(17):1961-1973. PubMed ID: 34792124
[TBL] [Abstract][Full Text] [Related]
28. Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.
Tanaka H; Tatsumi K; Matsuzoe H; Matsumoto K; Hirata KI
Cardiovasc Diabetol; 2020 Jun; 19(1):84. PubMed ID: 32534593
[TBL] [Abstract][Full Text] [Related]
29. Association of the frontal QRS-T angle with adverse cardiac remodeling, impaired left and right ventricular function, and worse outcomes in heart failure with preserved ejection fraction.
Selvaraj S; Ilkhanoff L; Burke MA; Freed BH; Lang RM; Martinez EE; Shah SJ
J Am Soc Echocardiogr; 2014 Jan; 27(1):74-82.e2. PubMed ID: 24075945
[TBL] [Abstract][Full Text] [Related]
30. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
31. Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure.
Kasperova BJ; Mraz M; Svoboda P; Hlavacek D; Kratochvilova H; Modos I; Vrzackova N; Ivak P; Janovska P; Kobets T; Mahrik J; Riecan M; Steiner Mrazova L; Stranecky V; Netuka I; Cajka T; Kuda O; Melenovsky V; Stemberkova Hubackova S; Haluzik M
Cardiovasc Diabetol; 2024 Jun; 23(1):223. PubMed ID: 38943140
[TBL] [Abstract][Full Text] [Related]
32. Determinants of reduced tricuspid annular plane systolic excursion in patients with severe systolic left ventricular dysfunction.
Ereminiene E; Vaskelyte JJ; Stoskute N; Kavoliuniene A; Bieseviciene M; Ordiene R; Nedzelskiene I
Acta Cardiol; 2012 Dec; 67(6):657-63. PubMed ID: 23393936
[TBL] [Abstract][Full Text] [Related]
33. SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently?
Al Rifai M; Newby LK; Nair AP; Misra A; Rogers JG; Fedson S; Virani SS
Curr Atheroscler Rep; 2022 Aug; 24(8):627-634. PubMed ID: 35653033
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
Li CX; Liang S; Gao L; Liu H
PLoS One; 2021; 16(2):e0244689. PubMed ID: 33606705
[TBL] [Abstract][Full Text] [Related]
35. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
36. Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction.
Schmeißer A; Rauwolf T; Groscheck T; Fischbach K; Kropf S; Luani B; Tanev I; Hansen M; Meißler S; Schäfer K; Steendijk P; Braun-Dullaeus RC
ESC Heart Fail; 2021 Aug; 8(4):2968-2981. PubMed ID: 33934536
[TBL] [Abstract][Full Text] [Related]
37. Association of insulin use with LV remodeling and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: assessed by cardiac MRI.
Shi K; Zhang G; Fu H; Huang S; Xu HY; Gao Y; Shi R; Yan WF; Qian WL; Li Y; Guo YK; Yang ZG
Cardiovasc Diabetol; 2023 Aug; 22(1):201. PubMed ID: 37542280
[TBL] [Abstract][Full Text] [Related]
38. Cardiac Power Output Is Independently and Incrementally Associated With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction.
Harada T; Yamaguchi M; Omote K; Iwano H; Mizuguchi Y; Amanai S; Yoshida K; Kato T; Kurosawa K; Nagai T; Negishi K; Anzai T; Obokata M
Circ Cardiovasc Imaging; 2022 Feb; 15(2):e013495. PubMed ID: 35144484
[TBL] [Abstract][Full Text] [Related]
39. Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment.
Cheng X; Huang P; Liu H; Bi X; Gao Y; Lu R; Gao Y; Liu Y; Deng Y
J Diabetes Investig; 2024 Jul; 15(7):851-860. PubMed ID: 38534028
[TBL] [Abstract][Full Text] [Related]
40. Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes.
Khan MS; Felker GM; Piña IL; Camacho A; Bapat D; Ibrahim NE; Maisel AS; Prescott MF; Ward JH; Solomon SD; Januzzi JL; Butler J
JACC Heart Fail; 2021 Feb; 9(2):137-145. PubMed ID: 33309581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
